Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Davis Polk Advises Huatai Securities on Its Acquisition of AssetMark
Davis Polk is advising Huatai Securities Co., Ltd. on its approximately $780 million acquisition of AssetMark Financial…
GoDaddy Inc. $574 Million Secondary Offering
Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 18,975,000…
GoDaddy Inc. $574 Million Secondary Offering
Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 18,975,000…
Société Générale $1.25 Billion Notes Offering
Davis Polk advised the dealers in connection with the offering by Société Générale of $750 million 2.500% fixed-rate notes…
Mizuho Financial Group, Inc. Senior Notes Offerings
Davis Polk advised the joint lead managers in connection with Rule 144A/Regulation S offerings by Mizuho Financial Group,…
Aeglea BioTherapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $54.8 million…
Davis Polk Advises Huatai Securities on Its Acquisition of AssetMark
Davis Polk is advising Huatai Securities Co., Ltd. on its approximately $780 million acquisition of AssetMark Financial…
Davis Polk Advises Wanhua Chemical Group on Tender Offer
Davis Polk advised Wanhua Chemical Group Co., Ltd. and Wanhua Chemical International Holding Co., Ltd. (“Wanhua Chemical…
Aeglea BioTherapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $54.8 million…
Aeglea BioTherapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $54.8 million…